Effective prevention of chronic graft versus host disease by anti-lymphocyte globulin after stem cell transplantation

A European Group for Blood and Marrow Transplantation (EBMT) labeled phase III clinical trial has found that the addition of anti-lymphocyte globulin (ATG) as part of the conditioning regimen in… Source link